March 11, 2024 · Form 4 insider transaction
Colleran David bought 3,682 shares of Anika Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Reflects the third and final vesting installment of Restricted Stock Units (RSUs) granted on March 9, 2021.; Includes the following shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan: 642 shares on May 12, 2023 and 192 shares on November 14, 2023.